IL‐6 (p = 0.1359) and CCL20 (p = 0.2973) expression was not significantly altered in TSC patient plasma EVs compared to unaffected healthy donor EVs (Figure 6f,g). This evidence concerns the gene IL6 and tuberous sclerosis.